Per
many citations, an example of the citation entitled “GxP Process Management
Software, Master Control, White Paper: Ten Most Common Reasons for FDA 483
Observations and Warning Letter Citations”, CAPA is among the top reason of the
citations. Examples are:
·
‘Corrective
and Preventive Action (CAPA) procedures are inadequate’.
·
‘Corrective
and Preventive Action are inadequately documented’.
Therefore,
sponsors should pay a lot of attention to CAPA, its initiation, implementation,
effectiveness, closure and documentation. Sponsor should have a system,
procedure, work instruction and forms and to assign responsibilities for the
initiating, requesting, implementing and verifying the effectiveness of CAPA.
The CAPA procedure applies to prevent and correct nonconformities related to
materials, components, subassemblies, finished products, manufacturing
processes and the whole quality system.
Some
of the associated documents with CAPA procedure are as follows:
·
Corrective
and Preventive Action Request Log
·
Corrective
and Preventive Action Request Form
·
Work
Instruction for Corrective and Preventive Action Request
·
Corrective
and Preventive Action Records.
Corrective
Actions are implemented to address actual nonconformities occurred in the
organization. Anyone can initiate a CAPA, but it is advisable that QA should
authorize CAPA request and review all CAPA for completeness and effectiveness
before closure.
CAPA request
includes a description of the unsatisfactory condition to be corrected and
explain how quality is impacted. CAPA request may be directed to the company's
internal departments as well as to its suppliers and subcontractors as well.
Examples
of cases which may initiate corrective actions are shown as follows:
·
Identification
of a nonconforming product;
·
Identified
problem with a manufacturing process or work operation;
·
A
nonconformity identified during a regulatory or third-party audit;
·
Field
performance problem reported by servicing;
·
Customer
or regulatory complaint like patient’s injury;
·
Nonconforming
delivery from a subcontractor;
·
Findings
from internal audit or customers;
·
Identification
of any other component, device, process or condition that does not conform to
specifications, documented quality system, or requirements of the ISO 13485
standard or 21 CFR 820.
Preventive
actions, however are initiated when quality performance data indicates that
there are trends of decreasing quality capability or effectiveness of the
quality system. For example: increasing incidence of product nonconformities
traceable to the same common cause; excessive equipment problems; or increasing
number of internal audit findings against the same element of the quality
system or department.
When a problem requiring preventive
action is identified, the process of dealing with the problem follows the same
steps that apply to corrective actions as described above.
Upon receiving a request for
corrective action or preventive action, the responsible manager investigates
the cause of the problem that initiated the request, proposes a corrective action
or preventive action to be taken, and indicates the date by which the
corrective action or preventive action will be fully implemented.
Another key concept for CAPA is the effectiveness of the
corrective action and preventive action taken to remediate the nonconformity. QA
should follow up with an inquiry or an audit to determine if the corrective
action or preventive action has been implemented effectively. When there is
objective evidence that the corrective action is effective, the CAPA can be
closed out. Examples of methods to gauge the effectiveness is the measurement
of any recurrences of the nonconformity or also perform trending for a certain
period after the corrective action and preventive action had been implemented. If
more work is needed to fully implement the action, a new follow-up date is set.
Sponsor
should also have a spreadsheet to track all the CAPA outstanding and ensure all
CAPAs are reasonably closed within a time-frame. I once have a client who get a
483 observation for not closing CAPA in 4 years.
The
following table show the exact wordings from www.fda.gov.
820.100
(a)
|
Has the
company established and maintained procedures for implementing corrective and
preventive actions inclusive of the necessary requirements identified in the
regulation?
|
820.100
(a)(1)
|
Do the
procedures include requirements for analyzing processes, work operations,
quality audit reports, quality records, service records, complaints, returned
product, and other sources of quality data to identify existing and potential
causes of nonconforming product, or other quality problems?
|
820.100
(a)(1)
|
Is
appropriate statistical methodology employed where necessary to detect
recurring quality problems?
|
820.100
(a)(2)
|
Do the
procedures include requirements for investigating the cause of
nonconformities relating to product, processes, and the quality system?
|
820.100
(a)(3)
|
Do the
procedures include requirements for identifying the action(s) needed to
correct and prevent recurrence of nonconforming product and other quality
problems?
|
820.100
(a)(4)
|
Do the
procedures include requirements for verifying or validating the corrective
and preventive actions to ensure that such action is effective and does not
adversely affect the finished device?
|
820.100
(a)(5)
|
Do the
procedures include requirements for implementing and recording changes in
methods and procedures needed to correct and prevent identified quality
problems?
|
820.100
(a)(6)
|
Do the
procedures include requirements for ensuring that information related to
quality problems or nonconforming products is disseminated to those directly
responsible for assuring the quality of such product or the prevention of
such problems?
|
820.100
(a)(7)
|
Do the
procedures include requirements for submitting relevant information on
identified quality problems, as well as corrective and preventive actions,
for management review?
|
820.100
(b)
|
Have
all corrective and preventive action activities been documented?
|
Disclaimer:
Although
the author had exhaustively researched all sources to ensure the accuracy and
completeness of the information contained in this blog, but no warranty and
fitness is implied. I assumed no responsibility and implied warranty of any
kind for errors, inaccuracies, omission, or any inconsistency herein. No
liability is assumed for incidental or consequential damages in connection with
the use of the information contained herein. Readers should always use their
own judgment and review all related regulatory guidelines. Guidelines can change
over time.
No comments:
Post a Comment